Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Flex Ltd (FLEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Flex Ltd — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Flex Ltd trades at $98.9 (market cap $40.97B). The key difference: Flex Ltd is far larger — about 10.4× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Flex Ltd for 6 Days on average.
| EWTX | FLEX | |
|---|---|---|
Market Cap | $3.94B | $40.97B |
Volume | 810,104 | 5,533,554 |
Sector | Health | Technology |
52-Week High | $48.35 | $162.07 |
52-Week Low | $14.89 | $54.51 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $3.48B | $44.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FLEX trades at $110.88, down 5.42% over the past day, amid a broader market pullback. The stock maintains a bullish technical trend with strong analyst support, including a consensus price target of $147.50. Recent acquisitions like EPC Power and the planned spin-off of Axiom highlight strategic moves to capitalize on AI data center and power infrastructure growth. Fundamentals show solid profitability with a net income margin of 3.32% and revenue growth to $29.3B projected for 2026.
The outlook for FLEX is positive, driven by expansion in AI infrastructure and consistent earnings beats. Investment opportunities include potential upside from the Axiom spin-off and continued demand in cloud and power sectors. Key risks involve integration challenges from acquisitions, competitive pressures, and market volatility affecting valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Flex Ltd
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →
